Cargando…
Sequential use of human-derived medium supplements favours cardiovascular tissue engineering
For clinical application of tissue engineering strategies, the use of animal-derived serum in culture medium is not recommended, because it can evoke immune responses in patients. We previously observed that human platelet-lysate (PL) is favourable for cell expansion, but generates weaker tissue as...
Autores principales: | Vis, Paul W Riem, Sluijter, Joost P G, Soekhradj-Soechit, R Sarita, van Herwerden, Lex A, Kluin, Jolanda, Bouten, Carlijn V C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822844/ https://www.ncbi.nlm.nih.gov/pubmed/21645237 http://dx.doi.org/10.1111/j.1582-4934.2011.01351.x |
Ejemplares similares
-
The pathophysiological basis of pharmacological interventions in CAVD
por: Riem Vis, P. W., et al.
Publicado: (2011) -
Calcification in Pulmonary Heart Valve Tissue Engineering: A Systematic Review and Meta-Analysis of Large-Animal Studies
por: van der Valk, Dewy C., et al.
Publicado: (2023) -
Tissue Engineered Materials in Cardiovascular Surgery: The Surgeon's Perspective
por: Durko, Andras P., et al.
Publicado: (2020) -
Early cost-utility analysis of tissue-engineered heart valves compared to bioprostheses in the aortic position in elderly patients
por: Huygens, Simone A., et al.
Publicado: (2020) -
(*)The Effects of Scaffold Remnants in Decellularized Tissue-Engineered Cardiovascular Constructs on the Recruitment of Blood Cells
por: Sanders, Bart, et al.
Publicado: (2017)